Fisher & Paykel Healthcare (NZSE:FPH) Effective Interest Rate on Debt % : 7.42% (As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Fisher & Paykel Healthcare's annualized positive value of Interest Expense for the quarter that ended in Sep. 2023 was NZ$17 Mil. Fisher & Paykel Healthcare's average total debt for the quarter that ended in Sep. 2023 was NZ$235 Mil. Therefore, Fisher & Paykel Healthcare's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2023 was 7.42%.

Fisher & Paykel Healthcare Effective Interest Rate on Debt % Historical Data

The historical data trend for Fisher & Paykel Healthcare's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Effective Interest Rate on Debt % Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

5.57

3.51

3.93

4.40

5.36

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															4.12	4.57	2.22	8.52	7.42

Competitive Comparison of Fisher & Paykel Healthcare's Effective Interest Rate on Debt %

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Effective Interest Rate on Debt % falls into.

Fisher & Paykel Healthcare Effective Interest Rate on Debt % Calculation

Fisher & Paykel Healthcare's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Mar. 2022 )	+	Total Debt (A: Mar. 2023 ))	/ count )
=	-1 * -6.7	/	( (104.3	+	145.8)	/ 2 )
=	-1 * -6.7	/	125.05
=	5.36 %

where

	Total Debt (A: Mar. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	87.3	+	17
=	104.3

	Total Debt (A: Mar. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	124.5	+	21.3
=	145.8

Fisher & Paykel Healthcare's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Mar. 2023 )	+	Total Debt (Q: Sep. 2023 ))	/ count )
=	-1 * -17.4	/	( (145.8	+	323.4)	/ 2 )
=	-1 * -17.4	/	234.6
=	7.42 %

where

	Total Debt (Q: Mar. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	124.5	+	21.3
=	145.8

	Total Debt (Q: Sep. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	299.6	+	23.8
=	323.4

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Sep. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Fisher & Paykel Healthcare (NZSE:FPH) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Fisher & Paykel Healthcare Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.